Efficacy of Cetylpyridinium Chloride mouthwash against SARS‐CoV‐2: A systematic review of randomized controlled trials

Abstract

AbstractIntroductionCOVID‐19 is a transmissible respiratory and multisystem disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Viral transmission occurs mainly through the spread of salivary droplets or aerosol from an infected subject. Studies suggest that salivary viral load is correlated with disease severity and probability of transmission. Cetylpyridinium chloride mouthwash has been found to be effective in reducing salivary viral load. The aim of this systematic review of randomized controlled trials is to evaluate the efficacy of the mouthwash ingredient cetylpyridinium chloride on salivary viral load in SARS‐CoV‐2 infection.MethodsRandomized controlled trials comparing cetylpyridinium chloride mouthwash with placebo and other mouthwash ingredients in SARS‐CoV‐2 positive individuals were identified and evaluated.ResultsSix studies with a total of 301 patients that met the inclusion criteria were included. The studies reported the efficacy of cetylpyridinium chloride mouthwashes in reduction on SARS‐CoV‐2 salivary viral load compared to placebo and other mouthwash ingredients.ConclusionMouthwashes containing cetylpyridinium chloride are effective against salivary viral load of SARS‐CoV‐2 in vivo. There is also the possibility that the use of mouthwash containing cetylpyridinium chloride in SARS‐CoV‐2 positive subjects could reduce transmissibility and severity of COVID‐19.